4.8 Article

FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis

期刊

EMBO JOURNAL
卷 29, 期 2, 页码 457-468

出版社

WILEY
DOI: 10.1038/emboj.2009.368

关键词

chromatin remodelling; haematopoiesis; lineage commitment; mast cell; transcriptional repression

资金

  1. National Institutes of Health [R01-HL071063, P50GM081892]
  2. American Heart Association

向作者/读者索取更多资源

The transcriptional co-factor Friend of GATA1 (FOG-1) has been shown to interact with subunits of the nucleosome remodelling and histone deacetylase (NuRD) complex through a specific motif located at its N-terminus. To test the importance of FOG-1/NuRD interaction for haematopoiesis in vivo, we generated mice with a mutation that specifically disrupts FOG-1/NuRD interaction (FOG-1(R3K5A)). Homozygous FOG-1(R3K5A) mice were found to have splenomegaly, extramedullary erythropoiesis, granulocytosis and thrombocytopaenia secondary to a block in megakaryocyte maturation. FOG-1(R3K5A/R3K5A) megakaryocytes and erythroid progenitors expressed increased levels of GATA2, showing that FOG-1/NuRD interaction is required for the earlier described 'GATA Switch'. In addition, ablation of FOG-1/NuRD interaction led to inappropriate expression of mast cell and eosinophil-specific genes in the megakaryocyte and erythroid lineages. Chromatin immunoprecipitation experiments revealed that the NuRD complex was not properly recruited to a mast cell gene promoter in FOG-1(R3K5A/R3K5A) megakaryocytes, suggesting that FOG-1/NuRD interaction is required for the direct suppression of mast cell gene expression. Taken together, these results underscore the importance of the FOG-1/NuRD interaction for the re-enforcement of lineage commitment during erythropoiesis and megakaryopoiesis in vivo. The EMBO Journal ( 2010) 29, 457-468. doi: 10.1038/emboj.2009.368; Published online 10 December 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia

Zibo Zhao, Lu Wang, Andrew G. Volk, Noah W. Birch, Kristen L. Stoltz, Elizabeth T. Bartom, Stacy A. Marshall, Emily J. Rendleman, Carson M. Nestler, Joseph Shilati, Gary E. Schiltz, John D. Crispino, Ali Shilatifard

GENES & DEVELOPMENT (2019)

Article Hematology

GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis

James Lally, Kristian Boasman, Lilia Brown, Vincenzo Martinelli, Ilaria Cappuccio, Vishaka Sovani, Christian Marinaccio, John D. Crispino, Ciaren Graham, Ciro Rinaldi

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Article Oncology

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial

Naseema Gangat, Christian Marinaccio, Ronan Swords, Justin M. Watts, Sandeep Gurbuxani, Alfred Rademaker, Angela J. Fought, Olga Frankfurt, Jessica K. Altman, Qiang Jeremy Wen, Noushin Farnoud, Christopher A. Famulare, Akshar Patel, Roberto Tapia, Rangit R. Vallapureddy, Stephanie Barath, Amy Graf, Amy Handlogten, Darci Zblewski, Mrinal M. Patnaik, Aref Al-kali, Yvonne Trang Dinh, Kristen Englund Prahl, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, Amber Thomassen, Juehua Gao, Peng Ji, Raajit K. Rampal, Francis J. Giles, Ayalew Tefferi, Brady Stein, John D. Crispino

CLINICAL CANCER RESEARCH (2019)

Article Oncology

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome

Maurice Labuhn, Kelly Perkins, Soeren Matzk, Leila Varghese, Catherine Garnett, Elli Papaemmanuil, Marlen Metzner, Alison Kennedy, Vyacheslav Amstislayskiy, Thomas Risch, Raj Bhayadia, David Samulowski, David Cruz Hernandez, Bilyana Stoilova, Valentina Lotchkova, Udo Oppermann, Carina Scheer, Kenichi Yoshida, Adrian Schwarzer, Jeffrey Taub, John D. Crispino, Mitchell J. Weiss, Asuhide Hayashi, Takashi Taga, Etsuro Ito, Seishi Ogawa, Dirk Reinhardt, Marie-Laure Yaspo, Peter J. Campbell, Irene Roberts, Stefan Constantinescu, Paresh Vyas, Dirk Heckl, Jan-Henning Klusmann

CANCER CELL (2019)

Article Oncology

Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo

Brittany Woods, Wei Chen, Sophia Chiu, Christian Marinaccio, Chunling Fu, Lilly Gu, Marinka Bulic, Qiong Yang, Anouar Zouak, Shengxian Jia, Praveen Kumar Suraneni, Kailin Xu, Ross L. Levine, John D. Crispino, Qiang Jeremy Wen

CLINICAL CANCER RESEARCH (2019)

Article Gastroenterology & Hepatology

Hepatocyte TNF Receptor-Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6-Linked Polyubiquitination of Apoptosis Signal-Regulating Kinase 1

Yutao Wang, Huan Wen, Jiajun Fu, Lin Cai, Peng-Long Li, Chang-Ling Zhao, Zhu-feng Dong, Jun-peng Ma, Xi Wang, Han Tian, Yan Zhang, Ye Liu, Jingjing Cai, Zhi-Gang She, Zan Huang, Wenhua Li, Hongliang Li

HEPATOLOGY (2020)

Article Hematology

Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis

Te Ling, Yehudit Birger, Monika J. Stankiewicz, Nissim Ben-Haim, Tomer Kalisky, Avigail Rein, Eitan Kugler, Wei Chen, Chunling Fu, Kevin Zhang, Hiral Patel, Jacek W. Sikora, Young Ah Goo, Neil Kelleher, Lihua Zou, Shai Izraeli, John D. Crispino

Review Oncology

Myelofibrosis in 2019: moving beyond JAK2 inhibition

Michael Schieber, John D. Crispino, Brady Stein

BLOOD CANCER JOURNAL (2019)

Article Medicine, Research & Experimental

Acute Megakaryocytic Leukemia

Maureen McNulty, John D. Crispino

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

GATA1 mutations in red cell disorders

Te Ling, John D. Crispino

IUBMB LIFE (2020)

Editorial Material Biochemistry & Molecular Biology

Preface to IUBMB life special issue on GATA transcription factors in development, differentiation, and disease

John Strouboulis, John D. Crispino

IUBMB LIFE (2020)

Article Cell Biology

TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation

Dan Liu, Peng Zhang, Junjie Zhou, Rufang Liao, Yan Che, Mao-Mao Gao, Jiaqi Sun, Jingjing Cai, Xu Cheng, Yongping Huang, Guopeng Chen, Hongyu Nie, Yan-Xiao Ji, Xiao-Jing Zhang, Zan Huang, Haibo Xu, Zhi-Gang She, Hongliang Li

CELL METABOLISM (2020)

Article Cell Biology

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Chongshu Jian, Jiajun Fu, Xu Cheng, Li-Jun Shen, Yan-Xiao Ji, Xiaoming Wang, Shan Pan, Han Tian, Song Tian, Rufang Liao, Kehan Song, Hai-Ping Wang, Xin Zhang, Yibin Wang, Zan Huang, Zhi-Gang She, Xiao-Jing Zhang, Lihua Zhu, Hongliang Li

CELL METABOLISM (2020)

Article Biochemistry & Molecular Biology

BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia

Manman Wang, Tan Zhang, Xuechun Zhang, Zhou Jiang, Min Peng, Zan Huang

CELL AND BIOSCIENCE (2020)

Article Oncology

USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia

Qi Jin, Carlos A. Martinez, Kelly M. Arcipowski, Yixing Zhu, Blanca T. Gutierrez-Diaz, Kenneth K. Wang, Megan R. Johnson, Andrew G. Volk, Feng Wang, Jian Wu, Charles Grove, Hui Wang, Ivan Sokirniy, Paul M. Thomas, Young Ah Goo, Nebiyu A. Abshiru, Nobuko Hijiya, Sofie Peirs, Niels Vandamme, Geert Berx, Steven Goosens, Stacy A. Marshall, Emily J. Rendleman, Yoh-hei Takahashi, Lu Wang, Radhika Rawat, Elizabeth T. Bartom, Clayton K. Collings, Pieter Van Vlierberghe, Alexandros Strikoudis, Stephen Kelly, Beatrix Ueberheide, Christine Mantis, Irawati Kandela, Jean-Pierre Bourquin, Beat Bornhauser, Valentina Serafin, Silvia Bresolin, Maddalena Paganin, Benedetta Accordi, Giuseppe Basso, Neil L. Kelleher, Joseph Weinstock, Suresh Kumar, John D. Crispino, Ali Shilatifard, Panagiotis Ntziachristos

CLINICAL CANCER RESEARCH (2019)

暂无数据